Yuki Kageyama to Androgen Antagonists
This is a "connection" page, showing publications Yuki Kageyama has written about Androgen Antagonists.
Connection Strength
0.776
-
Suppression of mutant androgen receptors by flutamide. Int J Urol. 2009 May; 16(5):516-21.
Score: 0.304
-
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors. Prostate. 2007 Jun 01; 67(8):799-807.
Score: 0.267
-
Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer. Prostate. 2008 Oct 01; 68(14):1570-81.
Score: 0.073
-
The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Pat Anticancer Drug Discov. 2007 Nov; 2(3):203-11.
Score: 0.069
-
Deferred combined androgen blockade therapy using bicalutamide in patients with hormone-refractory prostate cancer during androgen deprivation monotherapy. BJU Int. 2006 Jun; 97(6):1184-9.
Score: 0.062